Ignite Creation Date:
2025-12-24 @ 4:05 PM
Ignite Modification Date:
2026-01-23 @ 3:55 PM
Study NCT ID:
NCT06915766
Status:
AVAILABLE
Last Update Posted:
2025-11-05
First Post:
2025-03-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Expanded Access to Bezuclastinib for Patients With NonAdvanced Systemic Mastocytosis or Advanced Systemic Mastocytosis
Sponsor:
Cogent Biosciences, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CGT9486-IEAP-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None